Merit Medical Systems MMSI
$84.34 −$0.07 (-0.08%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $84.34 0.00%
Open$84.58
Prev close$84.41
Day range$83.89 – $86.20
Volume560.3K
Market cap$5.05B
P/E (TTM)31.6
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$416.24M+8.4% YoY
Operating profit$58.73M+37.7% YoY
Net profit$42.31M+52.4% YoY
Diluted EPS$0.70+52.2% YoY
Free cash flow$52.25M+1.4% YoY
Operating cash flow$65.27M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin49.4%
Operating margin13.5%
Net margin9.9%
Return on equity9.8%
Return on assets5.8%
Return on invested capital7.0%
Current ratio4.52
Liabilities / assets40.4%
Cash & investments$503.55M
Total debt$811.68M
Net cash (debt)-$308.13M
Free cash flow / sales12.4%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $416.24M | $418.84M | $381.88M | $1.52B | $393.94M |
| Total Operating Revenue | $416.24M | $418.84M | $381.88M | $1.52B | $393.94M |
| Cost of Revenue | $215.61M | $203.68M | $197.08M | $777.64M | $198.58M |
| Gross Profit | $200.63M | $215.17M | $184.80M | $738.27M | $195.35M |
| Operating Expense | $141.90M | $154.62M | $140.82M | $552.57M | $141.37M |
| Selling and Admin Expenses | $119.51M | $129.23M | $118.21M | $455.21M | $114.83M |
| Research & Development | $22.39M | $25.39M | $22.61M | $97.35M | $26.54M |
| Operating Profit | $58.73M | $60.55M | $43.98M | $185.70M | $53.98M |
| Net Non-Operating Interest Income (Expense) | -$3.21M | -$8.37M | -$2.63M | -$11.39M | -$2.46M |
| Non-Operating Interest Income | $4.13M | $3.75M | $3.90M | $15.07M | $3.90M |
| Non-Operating Interest Expense | $7.33M | $12.12M | $6.53M | $26.46M | $6.36M |
| Other Income (Expense) | $263,000.00 | -$868,000.00 | $12.19M | -$3.38M | -$461,000.00 |
| Special Income (Charges) | $36,000.00 | -$145,000.00 | $179,000.00 | -$984,000.00 | $214,000.00 |
| -Less:Restructuring and Mergern & Acquisition | -$36,000.00 | $145,000.00 | -$179,000.00 | $984,000.00 | -$214,000.00 |
| Other Non-Operating Income (Expenses) | $227,000.00 | -$723,000.00 | $12.02M | -$2.39M | -$675,000.00 |
| Pretax Profit | $55.79M | $51.31M | $53.55M | $170.94M | $51.06M |
| Tax | $13.47M | $12.51M | $12.55M | $42.45M | $13.05M |
| Net Profit | $42.31M | $38.80M | $41.00M | $128.49M | $38.01M |
| Profit from Continuing Operations | $42.31M | $38.80M | $41.00M | $128.49M | $38.01M |
| Net Income to Parent Company | $42.31M | $38.80M | $41.00M | $128.49M | $38.01M |
| Net Income to Common Stockholders | $42.31M | $38.80M | $41.00M | $128.49M | $38.01M |
| Basic EPS | $0.71 | $0.65 | $0.69 | $2.17 | $0.64 |
| Diluted EPS | $0.70 | $0.65 | $0.68 | $2.13 | $0.63 |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.92B | $2.86B | $2.72B | $2.69B | $2.69B |
| Total Current Assets | $1.20B | $1.11B | $1.10B | $1.04B | $1.04B |
| Cash and Cash Equivalents & Short-Term Investments | $503.55M | $448.70M | $488.08M | $446.40M | $446.40M |
| -Cash and Cash Equivalents | $503.55M | $448.70M | $488.08M | $446.40M | $446.40M |
| Receivables | $264.02M | $250.90M | $227.00M | $223.61M | $223.61M |
| -Accounts Receivable | $221.87M | $224.24M | $206.45M | $203.71M | $203.71M |
| -Taxes Receivable | $4.28M | $2.70M | $1.84M | $2.13M | $2.13M |
| -Other Receivables | $37.88M | $23.96M | $18.72M | $17.77M | $17.77M |
| Prepaid Assets | $5.03M | $5.03M | $5.03M | $4.94M | $4.94M |
| Inventory | $391.02M | $374.11M | $352.39M | $333.71M | $333.71M |
| Other Current Assets | $35.19M | $33.50M | $29.27M | $31.49M | $31.49M |
| Total Non-Current Assets | $1.73B | $1.75B | $1.62B | $1.65B | $1.65B |
| Net PPE | $521.73M | $520.53M | $520.33M | $516.00M | $516.00M |
| -Gross PPE | $918.17M | $910.87M | $903.01M | $892.45M | $892.45M |
| -Accumulated Depreciation | -$396.45M | -$390.34M | -$382.67M | -$376.45M | -$376.45M |
| Goodwill and Other Intangible Assets | $1.13B | $1.15B | $1.02B | $1.04B | $1.04B |
| -Goodwill | $537.14M | $539.77M | $503.43M | $506.84M | $506.84M |
| -Other Intangible Assets | $591.20M | $612.03M | $512.00M | $537.65M | $537.65M |
| Non-Current Deferred Assets | $7.27M | $7.20M | $7.09M | $29.86M | $29.86M |
| Other Non-Current Assets | $68.75M | $71.86M | $74.67M | $10.42M | $10.42M |
| Total Liabilities | $1.18B | $1.18B | $1.09B | $1.10B | $1.10B |
| Total Current Liabilities | $265.08M | $264.93M | $216.87M | $239.76M | $239.76M |
| Payables | $80.68M | $81.83M | $83.13M | $81.68M | $81.68M |
| -Accounts Payable | $66.29M | $70.74M | $67.85M | $60.55M | $60.55M |
| -Total Tax Payable | $14.39M | $11.09M | $15.28M | $8.85M | $8.85M |
| Current Accrued Expenses | $174.02M | $172.19M | $122.52M | $146.96M | $146.96M |
| Short-Term Debt and Capital Lease Obligation | $10.38M | $10.92M | $11.23M | $10.88M | $10.88M |
| -Current Capital Lease Obligation | $10.38M | $10.92M | $11.23M | $10.88M | $10.88M |
| Total Non-Current Liabilities | $915.27M | $918.88M | $875.68M | $861.86M | $861.86M |
| Long Term Accounts Payable and Other Payables | $19.37M | $19.30M | $17.37M | $17.54M | $17.54M |
| Long Term Debt and Capital Lease Obligation | $811.68M | $809.20M | $810.34M | $810.70M | $810.70M |
| -Long Term Debt | $737.40M | $736.26M | $735.16M | $734.04M | $734.04M |
| -Long Term Capital Lease Obligation | $74.27M | $72.94M | $75.18M | $76.66M | $76.66M |
| Non-Current Deferred Liabilities | $38.54M | $41.05M | $21.04M | $21.06M | $21.06M |
| Other Non-Current Liabilities | $45.69M | $49.34M | $26.94M | $12.55M | $12.55M |
| Total Equity | $1.74B | $1.68B | $1.63B | $1.58B | $1.58B |
| Stockholders' Equity | $1.74B | $1.68B | $1.63B | $1.58B | $1.58B |
| Capital Stock | $808.93M | $783.89M | $769.27M | $763.91M | $763.91M |
| -Common Stock | $808.93M | $783.89M | $769.27M | $763.91M | $763.91M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | $946.14M | $903.83M | $865.03M | $824.03M | $824.03M |
| Gains/Losses Not Affecting Retained Earnings | -$10.52M | -$7.92M | -$7.57M | -$3.64M | -$3.64M |
| Investments and Advances | – | – | – | $28.74M | $28.74M |
| Non-Current Note Receivables | – | – | – | $16.25M | $16.25M |
| -Other Payable | – | – | – | $12.28M | $12.28M |
| Current Deferred Liabilities | – | – | – | $247,000.00 | $247,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $65.27M | $69.28M | $40.68M | $297.37M | $98.51M |
| Net cash flow from continuing operations | $65.27M | $69.28M | $40.68M | $297.37M | $98.51M |
| Net Income from Continuing Operations | $42.31M | $38.80M | $41.00M | $128.49M | $38.01M |
| Gain/Loss from Continuing Operations | $902,000.00 | $693,000.00 | -$11.90M | $2.05M | $1.50M |
| Depreciation & Depletion & Amortization | $34.84M | $33.97M | $33.35M | $134.65M | $34.33M |
| Other Non-Cash Items | $1.35M | $1.53M | $1.21M | $6.54M | $1.17M |
| Change in Working Capital | -$28.02M | -$18.76M | -$32.07M | -$23.34M | $8.24M |
| -Change in Receivables | -$938,000.00 | -$20.49M | -$1.32M | -$2.73M | $8.95M |
| -Change in Inventory | -$16.29M | -$20.92M | -$22.66M | -$21.60M | -$6.53M |
| -Change in Prepaid Assets | -$3.23M | -$4.00M | $1.89M | -$4.13M | -$1.09M |
| -Change in Payables and Accrued Expense | -$445,000.00 | $29.75M | -$21.32M | $20.50M | $8.74M |
| -Change in Other Current Assets | -$304,000.00 | -$1.20M | -$723,000.00 | -$1.70M | $392,000.00 |
| -Change in Other Current Liabilities | -$6.90M | -$3.83M | $12.23M | -$12.03M | -$2.69M |
| -Change In Other Working Capital | $77,000.00 | $1.92M | -$169,000.00 | -$1.66M | $459,000.00 |
| Net cash flow from investing | -$22.32M | -$110.13M | $7.73M | -$247.39M | -$50.34M |
| Net Cash Flow from Continuing Investing Activities | -$22.32M | -$110.13M | $7.73M | -$247.39M | -$50.34M |
| Capital Expenditure | -$13.02M | -$18.19M | -$16.77M | -$84.84M | -$25.26M |
| Net Business Purchase and Sale | -$52,000.00 | -$91.94M | $24.50M | -$144.77M | -$22.23M |
| Financing Cash Flow | $11.61M | $948,000.00 | -$6.29M | $16.00M | $5.06M |
| Net Cash Flow from Continuing Financing Activities | $11.61M | $948,000.00 | -$6.29M | $16.00M | $5.06M |
| Net Common Stock Issuance | $11.65M | $1.85M | $2.78M | $28.21M | $6.03M |
| Net Other Financing Charges | -$39,000.00 | -$900,000.00 | -$9.06M | -$12.21M | -$972,000.00 |
| Ending Cash Balance | $505.79M | $450.91M | $490.25M | $448.55M | $448.55M |
| Net Change in Cash | $54.57M | -$39.91M | $42.13M | $65.98M | $53.24M |
| Beginning Cash Balance | $450.91M | $490.25M | $448.55M | $378.77M | $394.56M |
| Effect of Exchange Rate Changes | $314,000.00 | $566,000.00 | -$426,000.00 | $3.80M | $751,000.00 |
| Free Cash Flow | $52.25M | $51.09M | $23.92M | $212.54M | $73.25M |
| Deferred Tax | – | – | – | $5.21M | – |
| Net Other Investing Changes | – | – | – | -$17.78M | -$2.85M |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on MMSI.
Sign in to join the discussion.